A REVIEW OF THE INVITRO AND INVIVO NEUROCHEMICAL CHARACTERIZATION OF THE NMDA PCP GLYCINE ION CHANNEL RECEPTOR MACROCOMPLEX

Current neurochemical studies of the NMDA receptor macromolecular complex are yielding new insights into the interactions of the subunits of this complex and the associated potential clinical benefits of selective modulation of these subnits. Such studies offer the great potential for a new generation of pharmacotherapies for a wide range of CNS disorders, including stroke, a condition for which there is currently no effective pharmacological treatment. However, it is essential to understand that the first generation products in this area may not be optimal pharmacotherapies, such that haracterization of possible receptor subtypes and understanding the molecular biology of the component proteins of the receptor complex will be crucial in the design of the optimal pharmacological modulators of the NMDA receptor complex. © 1990 Plenum Publishing Corporation.